Scandinavian ChemoTech: Zapping Cancer
Initiating Coverage
2023-03-15
08:00
Redeye initiates coverage of Scandinavian ChemoTech, a Swedish medtech company in early-stage commercialisation with its tumour-specific electroporation (TSE) treatment method for both humans and animal cancer patients. Scandinavian ChemoTech awaits case study data from superficial and deep-seated tumours, and we believe its technology has the potential to disrupt the cancer market.
SA
FE
Sebastian Andersson
Filip Einarsson
Disclosures and disclaimers